Daiichi Sankyo extends Medidata use to China
Japan-based pharmaceutical company Daiichi Sankyo is expanding its use of Medidata Solutions' cloud-based platform to support clinical trials conducted by its division in China, an investment expected to streamline trial activities, improve the efficiency of data capture and increase the productivity of site users and clinical monitors. Daiichi Sankyo will bring Medidata's applications for electronic data capture, clinical data management and randomization and trial supply management to its expanding clinical work in China.
Daiichi Sankyo will have access to a cloud-based platform that provides a unified environment in which site staff will conduct patient randomization, supply dispensing and clinical data capture and enable collaboration and metrics visibility for the whole research team. Medidata CRO Tigermed was involved in the selection and implementation of the Medidata platform for the China-based work.